Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Neuromedin B identified as a therapeutic target for atopic dermatitis: evidence from Mendelian randomization and PCR validation

Submitted by Anna Hakala on Thu, 01/29/2026 - 11:59
  • Read more about Neuromedin B identified as a therapeutic target for atopic dermatitis: evidence from Mendelian randomization and PCR validation

HLA-A drives diabetic retinopathy pathogenesis: multi-omics integration reveals resveratrol’s therapeutic potential via immunomodulation

Submitted by Anna Hakala on Thu, 01/29/2026 - 11:57
  • Read more about HLA-A drives diabetic retinopathy pathogenesis: multi-omics integration reveals resveratrol’s therapeutic potential via immunomodulation

Integrative multi-omics and Mendelian randomization identify WWOX and THBS2 as potential therapeutic targets in mature T/NK-cell lymphoma

Submitted by Anna Hakala on Thu, 01/29/2026 - 11:57
  • Read more about Integrative multi-omics and Mendelian randomization identify WWOX and THBS2 as potential therapeutic targets in mature T/NK-cell lymphoma

Integrative eQTL and Mendelian randomization analysis reveals key genes in colorectal cancer

Submitted by Anna Hakala on Thu, 01/29/2026 - 11:51
  • Read more about Integrative eQTL and Mendelian randomization analysis reveals key genes in colorectal cancer

CXCL5/CXCR2 Axis Related to Neutrophilic Inflammation in Ulcerative Colitis: A Comprehensive Analysis Integrating eQTL, pQTL, and Transcriptome Data

Submitted by Anna Hakala on Mon, 01/26/2026 - 14:24
  • Read more about CXCL5/CXCR2 Axis Related to Neutrophilic Inflammation in Ulcerative Colitis: A Comprehensive Analysis Integrating eQTL, pQTL, and Transcriptome Data

Step change in glaucoma polygenic risk score performance enables clinical utility and disease prediction across all major ancestries

Submitted by Anna Hakala on Mon, 01/26/2026 - 11:52
  • Read more about Step change in glaucoma polygenic risk score performance enables clinical utility and disease prediction across all major ancestries

Glucagon-like peptide-1 receptor activation and mental health: a drug-target Mendelian randomization study

Submitted by Anna Hakala on Mon, 01/26/2026 - 11:50
  • Read more about Glucagon-like peptide-1 receptor activation and mental health: a drug-target Mendelian randomization study

Mapping the Proteomic Landscape of Aortic Aneurysm and Dissection in the Context of Hypertension

Submitted by Anna Hakala on Mon, 01/26/2026 - 11:49
  • Read more about Mapping the Proteomic Landscape of Aortic Aneurysm and Dissection in the Context of Hypertension

Family-GWAS reveals effects of environment and mating on genetic associations

Submitted by Anna Hakala on Mon, 01/26/2026 - 11:48
  • Read more about Family-GWAS reveals effects of environment and mating on genetic associations

Causal Relationships Between Soluble ST2, Heart Failure, and Sepsis: Bidirectional and Multivariable Mendelian Randomization Analyses

Submitted by Anna Hakala on Mon, 01/26/2026 - 11:47
  • Read more about Causal Relationships Between Soluble ST2, Heart Failure, and Sepsis: Bidirectional and Multivariable Mendelian Randomization Analyses

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Current page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement